2024-02-02 07:13:00 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)
- Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade)
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY24 outlook
- Regeneron Pharmaceuticals Q4 2023 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Regeneron posts Q4 beat even as Eylea, COVID-19 sales dip